200 related articles for article (PubMed ID: 15365685)
1. Neuroendocrine response to intravenous citalopram in healthy control subjects: pharmacokinetic influences.
Lotrich FE; Bies R; Muldoon MF; Manuck SB; Smith GS; Pollock BG
Psychopharmacology (Berl); 2005 Mar; 178(2-3):268-75. PubMed ID: 15365685
[TBL] [Abstract][Full Text] [Related]
2. L-5-Hydroxytryptophan augments the neuroendocrine response to a SSRI.
Lowe SL; Yeo KP; Teng L; Soon DK; Pan A; Wise SD; Peck RW
Psychoneuroendocrinology; 2006 May; 31(4):473-84. PubMed ID: 16378695
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses.
Nadeem HS; Attenburrow MJ; Cowen PJ
Neuropsychopharmacology; 2004 Sep; 29(9):1699-703. PubMed ID: 15127082
[TBL] [Abstract][Full Text] [Related]
4. Acute hormonal changes after IV citalopram and treatment response in OCD.
Corregiari FM; Gattaz WF; Bernik M
Psychopharmacology (Berl); 2007 Sep; 193(4):487-94. PubMed ID: 17492272
[TBL] [Abstract][Full Text] [Related]
5. Low-dose citalopram as a 5-HT neuroendocrine probe.
Attenburrow MJ; Mitter PR; Whale R; Terao T; Cowen PJ
Psychopharmacology (Berl); 2001 May; 155(3):323-6. PubMed ID: 11432696
[TBL] [Abstract][Full Text] [Related]
6. Specific effects of escitalopram on neuroendocrine response.
Hawken ER; Owen JA; Hudson RW; Delva NJ
Psychopharmacology (Berl); 2009 Nov; 207(1):27-34. PubMed ID: 19662384
[TBL] [Abstract][Full Text] [Related]
7. Acute citalopram administration produces correlated increases in plasma and salivary cortisol.
Bhagwagar Z; Hafizi S; Cowen PJ
Psychopharmacology (Berl); 2002 Aug; 163(1):118-20. PubMed ID: 12185409
[TBL] [Abstract][Full Text] [Related]
8. Effects of oral racemic citalopram on neuroendocrine responses.
Hawken ER; Owen JA; Van Vugt D; Delva NJ
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):694-700. PubMed ID: 16563590
[TBL] [Abstract][Full Text] [Related]
9. A comparison of d, l-fenfluramine and citalopram challenges in healthy adults.
Flory JD; Manuck SB; Perel JM; Muldoon MF
Psychopharmacology (Berl); 2004 Jul; 174(3):376-80. PubMed ID: 14997271
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine effects of a 20-mg citalopram infusion in healthy males. A placebo-controlled evaluation of citalopram as 5-HT function probe.
Seifritz E; Baumann P; Müller MJ; Annen O; Amey M; Hemmeter U; Hatzinger M; Chardon F; Holsboer-Trachsler E
Neuropsychopharmacology; 1996 Apr; 14(4):253-63. PubMed ID: 8924193
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine and subjective responses to pharmacological challenge with citalopram: a controlled study in male and female ecstasy/MDMA users.
Allott K; Canny BK; Broadbear JH; Stepto NK; Murphy B; Redman J
J Psychopharmacol; 2009 Sep; 23(7):759-74. PubMed ID: 18562414
[TBL] [Abstract][Full Text] [Related]
12. Effect of sleep deprivation on neuroendocrine response to a serotonergic probe in healthy male subjects.
Seifritz E; Müller MJ; Annen O; Nil R; Hatzinger M; Hemmeter U; Moore P; Holsboer-Trachsler E
J Psychiatr Res; 1997; 31(5):543-54. PubMed ID: 9368196
[TBL] [Abstract][Full Text] [Related]
13. The effects of an acute serotonergic challenge on brain-gut responses in irritable bowel syndrome patients and controls.
Kilkens TO; Honig A; Fekkes D; Brummer RJ
Aliment Pharmacol Ther; 2005 Nov; 22(9):865-74. PubMed ID: 16225497
[TBL] [Abstract][Full Text] [Related]
14. State and trait abnormalities in serotonin function in major depression.
Bhagwagar Z; Whale R; Cowen PJ
Br J Psychiatry; 2002 Jan; 180():24-8. PubMed ID: 11772847
[TBL] [Abstract][Full Text] [Related]
15. The citalopram challenge test in patients with major depression and in healthy controls.
Kapitany T; Schindl M; Schindler SD; Hesselmann B; Füreder T; Barnas C; Sieghart W; Kasper S
Psychiatry Res; 1999 Nov; 88(2):75-88. PubMed ID: 10622344
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine effects of citalopram, a selective serotonin re-uptake inhibitor, during lifespan in humans.
Berardelli R; Margarito E; Ghiggia F; Picu A; Balbo M; Bonelli L; Giordano R; Karamouzis I; Bo M; Ghigo E; Arvat E
J Endocrinol Invest; 2010 Oct; 33(9):657-62. PubMed ID: 20414043
[TBL] [Abstract][Full Text] [Related]
17. Serotonin modulation of cerebral glucose metabolism measured with positron emission tomography (PET) in human subjects.
Smith GS; Ma Y; Dhawan V; Gunduz H; Carbon M; Kirshner M; Larson J; Chaly T; Belakhleff A; Kramer E; Greenwald B; Kane JM; Laghrissi-Thode F; Pollock BG; Eidelber D
Synapse; 2002 Aug; 45(2):105-12. PubMed ID: 12112403
[TBL] [Abstract][Full Text] [Related]
18. Citalopram challenge in social anxiety disorder.
Shlik J; Maron E; Tru I; Aluoja A; Vasar V
Int J Neuropsychopharmacol; 2004 Jun; 7(2):177-82. PubMed ID: 14741063
[TBL] [Abstract][Full Text] [Related]
19. Lack of adverse interactions between concomitantly administered selegiline and citalopram.
Laine K; Anttila M; Heinonen E; Helminen A; Huupponen R; Mäki-Ikola O; Reinikainen K; Scheinin M
Clin Neuropharmacol; 1997 Oct; 20(5):419-33. PubMed ID: 9331518
[TBL] [Abstract][Full Text] [Related]
20. Hormone responses to citalopram in abstinent alcohol dependent subjects.
Gotjen D; Szabo Z; Lee S; Wand G
Alcohol Clin Exp Res; 2002 Nov; 26(11):1625-31. PubMed ID: 12436050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
